Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

Around five million Australians suffer from migraines, with women three times more likely to be affected than men ...

The obesity drug liraglutide cut migraine days in half in a small trial, though more research is needed to exclude the ...

A GLP-1 drug led to fewer days with headaches, a small pilot study of migraine sufferers shows. It may work by lowering pressure inside the head.

“Our findings show liraglutide may be effective for treating stubborn, high-frequency migraines in patients with obesity, and ...

A common diabetes drug may be the next big thing for migraine relief. In a clinical study, obese patients with chronic ...

A recent study suggests that liraglutide, a drug similar to Ozempic, may reduce migraine frequency in obese individuals with ...

Liraglutide, a medication commonly used to treat diabetes, has shown promising results in reducing chronic migraine in ...

Liraglutide, a member of the family of blockbuster weight-loss drugs, reduces headaches by half in a small study.

A small, early-stage study published in the journal Headache suggested a diabetes drug may ease migraines by lowering ...

Migraines are a common ailment worldwide, affecting nearly 15% of the global population. At times, they can be debilitating enough to interfere with daily activities. Despite a multitude of treatment ...

A 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with ...